During the past decade, Rhode Island Mood & Memory Research Institute conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 22 clinical trials were completed, i.e. on average, 84.6% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 11 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rhode Island Mood & Memory Research Institute" #1 sponsor was "Genentech, Inc." with 6 trials, followed by "Eli Lilly and Company" with 5 trials sponsored, "Pfizer" with 5 trials sponsored, "Biogen" with 4 trials sponsored and "AstraZeneca" with 4 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rhode Island Mood & Memory Research Institute" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Rhode Island Mood & Memory Research Institute" are "Alzheimer's Disease" (23 trials), "Alzheimer Disease" (13 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Early Alzheimer's Disease" (2 trials) and "Generalized Anxiety Disorder" (2 trials). Many other conditions were trialed in "Rhode Island Mood & Memory Research Institute" in a lesser frequency.

Most popular intervention types in "Rhode Island Mood & Memory Research Institute" are "Drug" (45 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "placebo" (4 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "Lanabecestat" (3 trials) and "[18F]GTP1" (3 trials). Other intervention names were less common.

The vast majority of trials in "Rhode Island Mood & Memory Research Institute" are 45 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Rhode Island Mood & Memory Research Institute". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 17 completed trials in Rhode Island Mood & Memory Research Institute, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Rhode Island Mood & Memory Research Institute, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".